Roche treatment of follicular lymphoma granted FDA orphan status
Genentech, a Roche company, received FDA orphan designation for its treatment of follicular lymphoma, according to a post to the agency’s website.https://thefly.com/landingPageNews.php?id=2838167
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.